| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1749-6632.2011.05970.X |
| P698 | PubMed publication ID | 21434938 |
| P50 | author | Max Ciarlet | Q90871618 |
| P2093 | author name string | Michelle G Goveia | |
| Colette S Ranucci | |||
| Katey E Owen | |||
| P2860 | cites work | Global impact of rotavirus vaccines | Q34108591 |
| Real-world impact of rotavirus vaccination | Q34156489 | ||
| Rotavirus infection in infants as protection against subsequent infections | Q34395807 | ||
| Rotavirus vaccines: current prospects and future challenges | Q34550164 | ||
| Global mortality associated with rotavirus disease among children in 2004. | Q34612610 | ||
| Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. | Q34626017 | ||
| Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua | Q34984560 | ||
| Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. | Q37631407 | ||
| Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq | Q37652537 | ||
| Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial | Q38879736 | ||
| Impact of acute rotavirus gastroenteritis on pediatric outpatient practices in the United States. | Q39760452 | ||
| Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States | Q39915484 | ||
| Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial | Q39944921 | ||
| Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants | Q40433532 | ||
| Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine | Q40489497 | ||
| Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation | Q40548550 | ||
| Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States | Q43962885 | ||
| Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine | Q44930427 | ||
| Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency. | Q45912376 | ||
| Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq | Q48064924 | ||
| Development and application of a quantitative RT-PCR potency assay for a pentavalent rotavirus vaccine (RotaTeq). | Q54637338 | ||
| Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine | Q58289465 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 14-18 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine | |
| P478 | volume | 1222 |
| Q58132934 | Bottlenecks, barriers, and solutions: results from multicountry consultations focused on reduction of childhood pneumonia and diarrhoea deaths |
| Q38022320 | Fulfilling the promise of rotavirus vaccines: how far have we come since licensure? |
| Q35806976 | Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq |
| Q30234848 | Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy |
| Q47832199 | Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh |
| Q58546255 | Multiple introductions and antigenic mismatch with vaccines may contribute to increased predominance of G12P[8] rotaviruses in the United States |
| Q38463606 | Multiple virus infection alters rotavirus replication and expression of cytokines and Toll-like receptors in intestinal epithelial cells |
| Q57922134 | Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine |
Search more.